An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders

3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)

NCT00872950 ·Status: APPROVED_FOR_MARKETING

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

NCT02970162 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Study on N-acetylneuraminic Acid

NCT01236898 ·Status: COMPLETED ·Phase: PHASE1

A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

NCT01377922 ·Status: COMPLETED ·Phase: PHASE3

Real-World Use of Novel Treatments in Patients With Spinal Muscular Atrophy (SMA): A Multi-Site Retrospective Chart Review of Pediatric SMA Patients Outside of the United States

NCT06178393 ·Status: COMPLETED

Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

NCT00994916 ·Status: NO_LONGER_AVAILABLE

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

NCT04886518 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome

NCT01498120 ·Status: COMPLETED ·Phase: PHASE2

Study of NMDA Antagonists and Neuropathic Pain

NCT01602185 ·Status: COMPLETED ·Phase: PHASE2

Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome

NCT01825395 ·Status: APPROVED_FOR_MARKETING

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

NCT04815967 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)

NCT06673056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Valproate and Levocarnitine in Children With Spinal Muscular Atrophy

NCT01671384 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT04003974 ·Status: COMPLETED ·Phase: PHASE2

Effect of Neuromuscular Blockade and Reversal on Breathing

NCT02845375 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome

NCT01511978 ·Status: COMPLETED ·Phase: PHASE2

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

NCT02562066 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

NCT04973657 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

NCT03196375 ·Status: TERMINATED ·Phase: PHASE2

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

NCT01455012 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS

NCT03319732 ·Status: COMPLETED ·Phase: PHASE3

Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)

NCT02090725 ·Status: TERMINATED ·Phase: PHASE2

Dimethyl Fumarate in Adrenomyeloneuropathy

NCT06513533 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

NCT05113745 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I

NCT00439218 ·Status: TERMINATED ·Phase: PHASE1/PHASE2